Haemochromatosis Risk

A blood-based DNA test for three HFE gene variants (C282Y, H63D, S65C) linked to genetic haemochromatosis, taken as a venous sample at a Randox Health clinic.

Sample
Blood
Collection
Venous draw at clinic
Results in
7 days
Biomarkers
3
Tests for
  • C282Y
  • H63D
  • S65C

Test specifications

Sample type
blood
Collection method
venous draw at clinic
Turnaround time
7 days
Biomarkers tested
3
At-home test
No
Doctor reviewed
No
Gender focus
Both

What's tested

3 biomarkers as listed by Randox Health.

  • C282Y
  • H63D
  • S65C

About this test

The Haemochromatosis Risk test analyses a venous blood sample for three variants in the HFE gene: C282Y, H63D and S65C. As with Randox Health's saliva-based version of this test, these variants are commonly used to assess genetic predisposition to haemochromatosis, an inherited condition linked to iron overload, and carrying a variant indicates increased risk rather than a diagnosis.

With three biomarkers, this sits in the lower range for clinical depth among the genetic and DNA tests we track, the same position as Randox Health's saliva-based Haemochromatosis Home Test, since both test the identical three variants. There are no comparable tests currently in our data to benchmark this price against.

Collection convenience scores low because it requires a venous blood draw at a clinic rather than an at-home kit, though results are returned faster, within 7 days, compared with the 1 to 2 weeks stated for the saliva-based version. The listing scores well for clarity and documentation, and trust signals remain high, reflecting Randox Health's Trustpilot rating of 4.6 from 29,705 reviews, its UKAS ISO 15189 accredited lab and CQC registration. Results and follow-up scores low because results are not reviewed by a doctor as standard.

Who is it for?

This may suit you if you have a family history of haemochromatosis or iron overload, would rather have a blood sample taken at a clinic than use a saliva kit at home, and want a faster turnaround. Randox Health's Haemochromatosis Home Test covers the same three HFE variants at the same £84 price using an at-home saliva sample instead, with results taking a little longer.

As with the saliva-based version, there are no other comparable genetic haemochromatosis tests in our data to weigh this against.

How it works

A nurse or doctor takes a venous blood sample at a Randox Health clinic, which is sent for genetic analysis of the C282Y, H63D and S65C variants in the HFE gene. Results are provided within 7 days of the sample reaching the lab and are not reviewed by a doctor as standard.

Pros & cons

Pros

  • Results in 7 days, faster than the 1 to 2 weeks for the saliva-based version.
  • Tests all three HFE variants most commonly linked to haemochromatosis risk.
  • Clinic-based blood draw may suit those who prefer not to self-collect at home.

Cons

  • Requires a venous blood draw at a clinic rather than an at-home kit.
  • No doctor reviews your results as standard.
  • No comparable tests in our data yet to check the £84 price against.

Our editorial score

Compare Health Test Score In-clinic version of Randox's haemochromatosis gene test
Editorial confidence: 9.0/10

This in-clinic blood test checks the same three HFE gene variants as Randox Health's saliva-based Haemochromatosis Home Test, at the same £84 price. The main difference is collection: this version needs a venous blood draw at a clinic rather than a saliva sample at home, though results come back faster, within 7 days rather than 1 to 2 weeks. It is not reviewed by a doctor as standard.

Score breakdown

  • Clarity and documentation 9.0/10

    The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.

  • Clinical depth 5.3/10

    3 biomarkers, placing it in the 13th percentile of genetic dna tests we track.

  • Collection convenience 5.0/10

    Requires a venous draw at a clinic; results in around 7 days, well ahead of the genetic dna norm of 14.

  • Results and follow-up 3.0/10

    Results are not doctor-reviewed and no consultation is included; the provider does not describe the report format.

  • Trust signals 9.0/10

    Trustpilot 4.6 from 29,705 reviews; accredited lab (UKAS ISO 15189 (Randox Clinical Laboratory Services, lab 9329)); CQC registered.

  • Value for money 6.0/10

    £84.00; no comparable tests to benchmark against yet.

Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.

View all →

Optimal DNA & Methylation Test

Ties for the deepest gene count among Stride's DNA panels

A cheek-swab DNA test covering 110 genes across methylation, nutrition, fitness, sleep, stress and skin. Suits people wanting Stride's fullest standalone DNA panel without the supplement bundle.

  • At-home test
8.2 / 10

Thalassaemia Screen Blood Test

Priciest test in its full blood count comparison group

An 18-marker blood test checking for thalassaemia traits and other red blood cell abnormalities using haemoglobin variants and a full blood count. Aimed at anyone investigating unexplained anaemia or a family or ethnic background linked to thalassaemia.

7.8 / 10

Optimal Duo

Combines Stride's DNA and gut microbiome tests in one bundle

A bundle combining Stride's 110-gene DNA & Methylation test with its Optimal Biome stool microbiome test and an expert consultation. Suits people wanting a combined genetic and gut health picture in one purchase.

  • At-home test
7.7 / 10